Skip to main content
. 2024 Feb 29;16(5):1012. doi: 10.3390/cancers16051012
ALDH Aldehyde Dehydrogenase
ARMS Alveolar rhabdomyosarcoma
COG Children’s Oncology Group
CSC Cancer stem cells
CYP Cytochrome P450
CWS Cooperative Weichteilsarkomen Studie
DME Drug-metabolising enzymes
EFS Event-free Survival
EpSSG European Paediatric Soft Tissue Sarcoma Study Group
ERMS Embryonal rhabdomyosarcoma
FNRMS Fusion-positive rhabdomyosarcoma
FPRMS Fusion-negative rhabdomyosarcoma
IRSG Intergroup Rhabdomyosarcoma Study Group
IVA Ifosfamide + vincristine + actinomycin D
PRMS Pleomorphic rhabdomyosarcoma
RMS Rhabdomyosarcoma
SIOP-MMT International Society of Paediatric Oncology–Malignant Mesenchymal Tumour Committee
STS Soft tissue sarcoma
STSC Soft Tissue Sarcoma Committee
TME Tumour microenvironment
VAC Vincristine + actinomycin D + cyclophosphamide